Changes in tumor and cardiac metabolism upon immune checkpoint.

Autor: Leven AS; Department of Dermatology, Venereology and Allergology, University Hospital Essen, University Duisburg-Essen, Essen, Germany. anna-sophia.leven@uk-essen.de., Wagner N; Department of Dermatology, Venereology and Allergology, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Nienaber S; Clinic III for Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany., Messiha D; Department of Cardiology and Vascular Medicine, West German Heart and Vascular Centre, University of Duisburg-Essen, Essen, Germany., Tasdogan A; Department of Dermatology, Venereology and Allergology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany.; National Center for Tumor Diseases (NCT)-West, Campus Essen, and Research Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany., Ugurel S; Department of Dermatology, Venereology and Allergology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site Essen/Düsseldorf, Essen, Germany.; National Center for Tumor Diseases (NCT)-West, Campus Essen, and Research Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany.

Publikováno v: Basic research in cardiology [Basic Res Cardiol] 2024 Dec 10. Date of Electronic Publication: 2024 Dec 10.

Tumor necrosis factor receptor 2 promotes endothelial cell-mediated suppression of CD8+ T cells through tuning glycolysis in chemoresistance of breast cancer.

Autor: Hu, Yu¹ (AUTHOR), Lou, Xiaohan¹ (AUTHOR), Zhang, Kaili¹ (AUTHOR), Pan, Longze^1,2 (AUTHOR), Bai, Yueyue^1,3 (AUTHOR), Wang, Linlin¹ (AUTHOR), Wang, Ming¹ (AUTHOR), Yan, Yan¹ (AUTHOR), Wan, Jiajia¹ (AUTHOR), Yao, Xiaohan¹ (AUTHOR), Duan, Xixi¹ (AUTHOR), Ni, Chen¹ (AUTHOR) nichen904@163.com, Qin, Zhihai¹ (AUTHOR) zhihai@ibp.ac.cn

Publikováno v: Journal of Translational Medicine. 7/20/2024, Vol. 22 Issue 1, p1-22. 22p.

Alpha4beta1-integrin activation is necessary for high-efficiency T-cell subset interactions with VCAM-1 under flow

Autor: Yc, Lim, Mw, Wakelin, Henault L, Dj, Goetz, Yednock T, Cabañas C, Francisco Sánchez-Madrid, Ah, Lichtman, Fw, Luscinskas

Publikováno v: Europe PubMed Central

The purpose of this study was to examine the relationship between alpha4beta1-integrin state of activation on CD4+ T-cell subsets and their adhesive interaction to VCAM-1 under flow.Human CD4+ memory and naive T-cells were freshly isolated and effect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::673d5164d6563947ce36a60bc869a6a8
https://pubmed.ncbi.nlm.nih.gov/10901499

Cardiovascular disease burden in patients with urological cancers: The new discipline of uro‐cardio‐oncology.

Autor: Zheng, Yi¹ (AUTHOR), Liu, Ying¹ (AUTHOR), Chen, Ziliang¹ (AUTHOR), Zhang, Yunpeng¹ (AUTHOR), Qi, Zuo¹ (AUTHOR), Wu, Ning¹ (AUTHOR), Zhao, Zhiqiang¹ (AUTHOR), Tse, Gary^1,2 (AUTHOR), Wang, Yong¹ (AUTHOR), Hu, Hailong¹ (AUTHOR), Niu, Yuanjie¹ (AUTHOR), Liu, Tong¹ (AUTHOR) liutong@tmu.edu.cn

Publikováno v: Cancer Innovation. Apr2024, Vol. 3 Issue 2, p1-17. 17p.

Immune checkpoint inhibitors in cancer: the increased risk of atherosclerotic cardiovascular disease events and progression of coronary artery calcium.

Autor: Gong, Bingxin^1,2 (AUTHOR), Guo, Yusheng^1,2 (AUTHOR), Li, Yi^1,2 (AUTHOR), Wang, Jing^1,2 (AUTHOR), Zhou, Guofeng^1,2 (AUTHOR), Chen, Yong-hao³ (AUTHOR), Nie, Tong^1,2 (AUTHOR), Yang, Ming^1,2 (AUTHOR), Luo, Kun^1,2 (AUTHOR), Zheng, Chuansheng^1,2 (AUTHOR), Pan, Feng^1,2 (AUTHOR), Liang, Bo^1,2 (AUTHOR) xiehelb@sina.com, Yang, Lian^1,2 (AUTHOR) yanglian@hust.edu.cn

Publikováno v: BMC Medicine. 1/31/2024, Vol. 22, p1-13. 13p.